An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression.
Zhang P, Shi B, Gao H, Jiang H, Kong J, Yan J, Pan X, Li K, Zhang P, Yao M, Yang S, Gu J, Wang H, Li Z.
Zhang P, et al. Among authors: yan j.
Cancer Immunol Immunother. 2014 Feb;63(2):121-32. doi: 10.1007/s00262-013-1497-4. Epub 2013 Nov 1.
Cancer Immunol Immunother. 2014.
PMID: 24177984
Free PMC article.